Assignee
NANJING SOUTHERN ELEMENT BIOTECHNOLOGY CO LTD
CN·1 granted patent·3 pending applications·0 citations·filing 2022–2024
Top patents by PatentIndex Score
4 records- 0159US11819514B2Use of oligosaccharide riclinoctaose in preparation of drug for treating and/or preventing ischemia-reperfusion injury (IRI)NANJING SOUTHERN ELEMENT BIOTECHNOLOGY CO LTD·Filed 2022·Granted Nov 21, 2023·0 cites·8 claims
- 0258US2025205386A1Glucogalactan-based injectable subcutaneous filling hydrogel, and preparation method and use thereofNANJING SOUTHERN ELEMENT BIOTECHNOLOGY CO LTD·Filed 2024·Application pending·0 cites
- 0354US2024000993A1Paenibacillus strain, and hemostatic polysaccharide produced by same and use thereofNANJING SOUTHERN ELEMENT BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 0448US2023144882A1Use of adenosine deaminase and adenosinedeaminase modifier in preparation of medicamentfor wound repair in patient with diabetesNANJING SOUTHERN ELEMENT BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NANJING SOUTHERN ELEMENT BIOTECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →